Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • AChR
    (1)
  • GPCR
    (1)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Metabolism
    (2)
  • Cardiovascular System
    (1)
Filter
Search Result
Results for "

dyslipidaemia

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • GSK256073
    T15432862892-90-8
    GSK256073 is an orally active GPR109A agonist. GSK256073 also is a long-lasting and non-flushing HCA2 (hydroxy-carboxylic acid receptor 2) full agonist (pEC50: 7.5). GSK256073 acutely improves glucose homeostasis via inhibition of lipolysis.
    • $67
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • SCH-900271
    SCH 900271
    T34573915210-50-3In house
    SCH-900271 is a potent nicotinic acid receptor for the treatment of dyslipidaemia and is commonly used in the study of mixed hyperlipidaemia and primary hypercholesterolaemia.
    • $120
    In Stock
    Size
    QTY
  • AZD-4121 tert-butylammonium
    T708481369489-35-9
    AZD-4121 tert-butylammonium is an oral cholesterol absorption inhibitor targeting NPC1L1 for the treatment of dyslipidaemia.
    • $2,570
    10-14 weeks
    Size
    QTY
  • AZD-4121
    T708491369489-34-8
    AZD-4121 is an oral cholesterol absorption inhibitor targeting NPC1L1 for the treatment of dyslipidaemia.
    • $2,570
    10-14 weeks
    Size
    QTY